022 24172311
Sections
Search
DealCurry
Equity
Venture Capital
Private Equity
M&A

Banner
DataBoard Demo
Private Equity | 8 September 2010

Actis, Sequoia Plan Stake Sale In Paras Pharma For $700 Mn

by Deeshesh Chheda
Actis, Sequoia Plan Stake Sale In Paras Pharma For $700 Mn
Share on Social Media Email Facebook Twitter Linkedin
 
@deeshesh

Private equity firms Actis Capital and Sequoia Capital are planning to sell a controlling stake in FMCG company Paras Pharmaceuticals Limited for $700 million.

The private equity firms decided to sell their shares after receiving interest from drugmakers including GlaxoSmithKline, Sanofi-Aventis and Abbott Laboratories.

Actis, a private equity firm that invests in emerging markets, holds about 62% in Paras and Sequoia holds about 8%, while Paras Chairman Girish Patel and employees own the remaining stake.

Transaction Reference: BS


{TAG_9638_1283930409}

Century Real Estate Raises Rs 100 Cr Via NCDs

Century Real Estate Raises Rs 100 Cr Via NCDs

Century Real Estate Holdings, the real estate arm of the Century Group has raised Rs.100 crore though private placement of NCDs last week.

Read More...

Snapdeal raises $21m from Luxembourg Clouse SA

Snapdeal raises $21m from Luxembourg Clouse SA

Jasper Infotech Pvt. Ltd., that regulates e-commerce platform Snapdeal, has raised over $21 million as part of its earlier announced funding round from Luxembourg-based firm Clouse SA. As a separate entity, BlackRock Inc. - the mutual-fund investor in Snapdeal has also retained its valuation in the digital marketplace.

Read More...
Subscribe
Enter your Email address
to receive all the news